OrthoPediatrics KIDS Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net revenue by Product | ||||||
| Scoliosis | $67.83M+2.7% | $66.05M+3.1% | $64.08M+1.0% | $63.45M+8.3% | $58.61M+6.3% | |
| Sports medicine/other | $4M-0.1% | $4M+22.9% | $3.26M-12.1% | $3.71M-10.7% | $4.15M-6.7% | |
| Trauma and deformity | $171.48M+3.1% | $166.3M+3.9% | $160.08M+4.2% | $153.58M+2.6% | $149.69M+3.1% | |
| Net revenue by Geography | ||||||
| International | $52.48M+5.1% | $49.95M+6.8% | $46.76M+1.5% | $46.09M+3.1% | $44.71M+2.6% | |
| U.S. | $190.82M+2.4% | $186.4M+3.2% | $180.65M+3.4% | $174.65M+4.1% | $167.75M+4.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does OrthoPediatrics break its business down?
- OrthoPediatrics (KIDS) reports net revenue by product across 3 parts — Scoliosis, Sports medicine/other and Trauma and deformity. Each is extracted from the segment footnotes and tracked over time.
- Where does OrthoPediatrics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in OrthoPediatrics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
